HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laparoscopic management of refractory chylous ascites using fluorescence navigation with indocyanine green: A case report.

AbstractINTRODUCTION:
Postoperative chylous ascites is a rare complication of colorectal surgery. Conservative management is usually effective in most cases of the postoperative chylous ascites. However, surgical intervention is performed for refractory cases.
PRESENTATION OF CASE:
A 31-year-old man with neuroendocrine carcinoma developed chylous ascites after laparoscopic descending colectomy with D3 lymphadenectomy. Conservative treatment including total parenteral nutrition and somatostatin analogue failed and surgical intervention via laparoscopy was performed for the refractory chylous ascites. Lymphatic leakage was detected at the upper part of the inferior mesenteric artery during the laparoscopic exploration and was reconfirmed by intraoperative indocyanine green injection with an infrared camera system. Moreover, we injected the ICG into the other sites of the lymphadenectomy performed and identified the lymphatic flow. We confirmed there was no other lymphatic leakage. The lesion was ligated and closed with fibrin glue. Five months after the surgical intervention, no symptom was noted.
DISCUSSION:
It is frequently difficult to detect the site of lymphatic leakage intraoperatively. Intraoperative indocyanine green injection is useful for detecting a lymphatic leakage site and especially making sure without other leakages. Additionally, laparoscopic surgery seems safe and effective for refractory chylous ascites.
CONCLUSION:
we reported successful laparoscopic management of refractory chylous ascites using fluorescence navigation with indocyanine green.
AuthorsHiroto Shimajiri, Hiroyuki Egi, Masateru Yamamoto, Masatoshi Kochi, Shoichiro Mukai, Hideki Ohdan
JournalInternational journal of surgery case reports (Int J Surg Case Rep) Vol. 49 Pg. 149-152 ( 2018) ISSN: 2210-2612 [Print] Netherlands
PMID30007263 (Publication Type: Journal Article)
CopyrightCopyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: